Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-24

FDA Approved: VESTURA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VESTURA (drospirenone and ethinyl estradiol) from Teva, updating labeling to support its use as a combined oral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VESTURA (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for VESTURA (DROSPIRENONE AND ETHINYL ESTRADIOL)